BioCentriq

10:30 AM - 10:45 AM (PDT), Wednesday, June 15, 2022
BioCentriq is a state-of-the-art Cell and Gene Therapy Development and cGMP Manufacturing Center for flexible process development and clinical manufacturing. The company specializes in 1) Cell Therapy (CAR-T, T-cell, Stem cell, NK and Dendritic cell) and 2) Gene therapy/viral vector production (AAV, LVV, AV).

BioCentriq facilities are ISO-7 certified, FDA registered and offer full hybrid team access to clinical and preclinical clients to work alongside experienced development, manufacturing and quality teams. All IP generated at BioCentriq is assigned to sponsoring clients.

The center currently has both PD and manufacturing capacity to support projects in 2022 and 2023.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
Not applicable
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Director, Business Development
BioCentriq